Litcius/Paper detail

Current developments in extracellular-regulated protein kinase (ERK1/2) inhibitors

Yuzhen Niu, Hong‐Fang Ji

2022Drug Discovery Today24 citationsDOI

Topics & Concepts

Extracellular signal-regulated kinasesKinaseMAPK/ERK pathwayDrug discoverySignal transductionExtracellularComputational biologyPharmacologyBiologyBioinformaticsCell biologyMedicineCancer researchMelanoma and MAPK PathwaysComputational Drug Discovery MethodsCytokine Signaling Pathways and Interactions
Current developments in extracellular-regulated protein kinase (ERK1/2) inhibitors | Litcius